Indication: Bladder Cancer
A Phase Ib/II Open Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Locally Advanced Or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy (MORPHEUS-mUC)
Sub-indication: Genitourinary Cancer
Study Type: Drug Study
Principal Investigator: Chandler Park, M.D.Norton Cancer Institute
Sponsor: Sponsor: F. Hoffmann-LaRoche Ltd.
Learn more at ClinicalTrials.gov
Email for more information: GU-NCIResearch@nortonhealthcare.org
